403 related articles for article (PubMed ID: 18171018)
21. Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
Want E
Bioanalysis; 2009 Jul; 1(4):805-19. PubMed ID: 21083139
[TBL] [Abstract][Full Text] [Related]
22. Selection of biomarkers by a multivariate statistical processing of composite metabonomic data sets using multiple factor analysis.
Dumas ME; Canlet C; Debrauwer L; Martin P; Paris A
J Proteome Res; 2005; 4(5):1485-92. PubMed ID: 16212398
[TBL] [Abstract][Full Text] [Related]
23. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets.
Stoyanova R; Nicholson JK; Lindon JC; Brown TR
Anal Chem; 2004 Jul; 76(13):3666-74. PubMed ID: 15228339
[TBL] [Abstract][Full Text] [Related]
24. High-resolution NMR for metabomics.
Pelczer I
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):127-33. PubMed ID: 15679180
[TBL] [Abstract][Full Text] [Related]
25. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
Witkamp RF
J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
[TBL] [Abstract][Full Text] [Related]
26. Mixtures of similarly acting compounds in Daphnia magna: from gene to metabolite and beyond.
Vandenbrouck T; Jones OA; Dom N; Griffin JL; De Coen W
Environ Int; 2010 Apr; 36(3):254-68. PubMed ID: 20117838
[TBL] [Abstract][Full Text] [Related]
27. Nutritional metabonomics: applications and perspectives.
Rezzi S; Ramadan Z; Fay LB; Kochhar S
J Proteome Res; 2007 Feb; 6(2):513-25. PubMed ID: 17269708
[TBL] [Abstract][Full Text] [Related]
28. Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis.
Wagner S; Scholz K; Donegan M; Burton L; Wingate J; Völkel W
Anal Chem; 2006 Feb; 78(4):1296-305. PubMed ID: 16478125
[TBL] [Abstract][Full Text] [Related]
29. Toxicogenomics in biomarker discovery.
Decristofaro MF; Daniels KK
Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
[TBL] [Abstract][Full Text] [Related]
30. [Recent advances in metabonomics].
Xu GW; Lu X; Yang SL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):701-11. PubMed ID: 18595244
[TBL] [Abstract][Full Text] [Related]
31. Protein biomarkers for in vitro testing of toxicology.
Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K
Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942
[TBL] [Abstract][Full Text] [Related]
32. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
33. Metabonomics: systems biology in pharmaceutical research and development.
Lindon JC; Holmes E; Nicholson JK
Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
[TBL] [Abstract][Full Text] [Related]
34. Statistical search space reduction and two-dimensional data display approaches for UPLC-MS in biomarker discovery and pathway analysis.
Crockford DJ; Lindon JC; Cloarec O; Plumb RS; Bruce SJ; Zirah S; Rainville P; Stumpf CL; Johnson K; Holmes E; Nicholson JK
Anal Chem; 2006 Jul; 78(13):4398-408. PubMed ID: 16808447
[TBL] [Abstract][Full Text] [Related]
35. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
[TBL] [Abstract][Full Text] [Related]
36. A gender-specific discriminator in Sprague-Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification.
Hodson MP; Dear GJ; Roberts AD; Haylock CL; Ball RJ; Plumb RS; Stumpf CL; Griffin JL; Haselden JN
Anal Biochem; 2007 Mar; 362(2):182-92. PubMed ID: 17266915
[TBL] [Abstract][Full Text] [Related]
37. [Role of biomarkers in toxicity treatment "metabonomics" as a new biomarker discovery method].
Naraoka H; Suzumura K; Takeuchi K; Sasayama T
Rinsho Byori; 2008 Apr; 56(4):335-42. PubMed ID: 18516969
[TBL] [Abstract][Full Text] [Related]
38. Recursive segment-wise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery.
Veselkov KA; Lindon JC; Ebbels TM; Crockford D; Volynkin VV; Holmes E; Davies DB; Nicholson JK
Anal Chem; 2009 Jan; 81(1):56-66. PubMed ID: 19049366
[TBL] [Abstract][Full Text] [Related]
39. A metabonomic approach for mechanistic exploration of pre-clinical toxicology.
Coen M
Toxicology; 2010 Dec; 278(3):326-40. PubMed ID: 20699110
[TBL] [Abstract][Full Text] [Related]
40. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics.
Lindon JC; Nicholson JK
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():45-69. PubMed ID: 20636074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
